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Introduction 1
The accumulation of fatty acids (FAs) in skeletal muscle (SKM), caused by chronic over-2 nutrition where the energetic supply exceeds mitochondrial oxidative capacity, is a prominent 3 patho-physiological mechanism linking obesity to insulin resistance and related metabolic diseases mutations that alter UCP3 function to the development of obesity and type II diabetes in 1 susceptible human populations (Schrauwen et al. 1999; Schrauwen et al. 2001; Liu et al. 2005; 2 Musa et al. 2011). In addition to this, animal studies have shown that overexpression of UCP3 in 3 SKM not only increases FA metabolism and protects against oxidative stress (MacLellan et al. 4 2005), but also enhances glucose homeostasis (Choi et al. 2007; Huppertz et al. 2001; Clapham et 5 al. 2000) . However, the molecular mechanisms that govern UCP3 function in obesity and FA 6 metabolism are not well understood. 7 This study advances our understanding of the mechanisms that link UCP3 function to FA 8 metabolism in SKM, as a means to relieve mitochondrial overload and metabolic stress. Here we 9 show that UCP3 directly interacts with the auxiliary, unsaturated FA metabolizing enzyme enoyl 10 CoA hydratase-1 (ECH1) in the mitochondrial matrix. Unlike saturated FAs that can readily 11 undergo mitochondrial b-oxidation, unsaturated FA metabolism is more complex and requires a 12 set of specific auxiliary enzymes that permit the complete oxidation of these particular FA species.
13
ECH1 is an essential enzyme in the reductase-dependent pathway, which is one of the two branches 14 that can metabolize unsaturated FAs with double bonds in odd-numbered positions along the 15 carbon chain (Luo et al. 1994 ). In the reductase-pathway, ECH1 catalyzes the isomerization of a 16 3-trans, 5-cis dienoyl-CoA substrate to a 2-trans, 4-trans dienoyl-CoA product (Filppula 1998; 17 Luthria et al. 1995)-a step that permits the complete oxidation of these specific FA metabolites. 18 Although little is known about the physiological relevance of ECH1, it has been proposed that flux 19 through the reductase-dependent pathway is important in facilitating complete FA metabolism, 20 thus protecting mitochondrial oxidative function and preventing metabolic stress (Shoukry & 21 Schulz 1998). This hypothesis is supported by studies where accumulation of the 3,5 enoyl-CoA 22 derivative is shown to strongly inhibit beta-oxidation in E. coli that do not endogenously express 23 Generation of stable C2C12 cell lines 1 The Precision LentiORF lentiviral packaging system was obtained from Thermo Fisher Scientific 2 (Waltham, MA). Full-length ECH1 was cloned into the pLOC lentiviral plasmid following the 3 manufacturer's instructions. HEK293T packaging cells were transfected with the pLOC lentiviral 4 plasmid and two viral packaging plasmids pMDG2 and psPAX2, using a standard calcium 5 phosphate transfection method to produce the lentiviral particles. The HEK293T cells were 6 incubated with the transfection complexes in normal growth media supplemented with 25µM 7 choloroquinone for 8 hours. Forty hours after transfection, the virus containing media was 8 harvested. To concentrate the lentiviral particles, the Lenti-X Concentrator reagent (Clonetech, 9 Mountainview, CA) was used according to the manufacturer's protocols. For lentiviral 10 transduction, C2C12 myocytes were seeded in 6 well plates at 50,000 cells/wells one day prior to 11 infection. The cells were then incubated with the concentrated lentiviral particles in full growth 12 media supplemented with polybrene (8µg/mL), overnight. Following infection, stable cell 13 colonies were selected with 25µg/mL of blasticidin. Positive colonies were then confirmed 14 through immunoblotting and densitometry. 15 Animals 16 C57BL/6J wild-type mice were obtained from Jackson Laboratories (Bar Harbor, ME). The UCP3 17 knockout mice (UCP3 -/-) in the C57BL/6J background were a gift from Dr. Marc Reitman, formerly 18 of the National Institutes of Health. The UCP1 knockout mice (UCP1 -/-) were a gift from Dr. Leslie
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Kozak of the Pennington Biomedical Research Institute. The UCP3 -/-mice were crossed with the 20 UCP1 -/-mice to generate our UCP1 and UCP3 double knockout line (UCP1 -/-+ UCP3 -/-). The 21 transgenic mice overexpressing human UCP3 in SKM generated from human alpha1-actin 22 promoter targeting construct (TgSKM UCP3 +/+ ) were a gift from Dr. Mary-Ellen Harper of the 1 University of Ottawa. The TgSKM UCP3 +/+ were then crossed with the UCP3 -/-and DKO lines to 2 generate a transgenic mouse overexpressing human UCP3 in SKM in the UCP3 -/-and DKO 3 background (TgSKM UCP3 -/-and TgSKM UCP1 -/-+ UCP3 -/-, respectively). It is important to note 4 that all TgSKM-UCP3 strains were kept as hemizygous breeder colonies.
5
Unless otherwise noted, all experiments were performed in male mice between the ages of 6-8.5 6 weeks. All animal husbandry and procedures were carried out in accordance to the Association 7 for Assessment and Accreditation of Laboratory Animal Care (AAALAC) and approved by the 8 Institutional Animal Care and Use Committee at The University of Texas at Austin (IACUC).
9
Generation of ECH1 -/-mouse model 10 The custom designed CompoZr ® Zinc Finger Nuclease Plasmid targeted to exon 3 of the mouse 11 ECH1 gene on chromosome 7 was obtained from Sigma. In-vitro transcription of the ZFN mRNA 12 was performed following the manufacturer's instructions. mRNA was transfected in cultured cells 13 to validate activity using a Cel-I enzymatic mutation detection assay. The ZFN mRNA (10ng/µl) 14 was then microinjected into 330 mouse BDF1 embryos and implanted into pseudopregnant female 15 mice recipients.
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Genotyping of founders (F0) was done using genomic PCR with the primers following primers 17 provided by Sigma, forward 5'-CGCGATGACAGTTTCCAGTA-3' reverse 5'-18 CAAACAAAAACCCACTGAGGA-3'. In order to perform DNA sequence analysis, amplified 19 bands of the ZFN target site were cloned in to the pGEM-T Easy Vector system (Promega, 20 Madison, WI) and sequenced by the University of Texas at Austin's DNA Sequencing Facility.
21
Two founders (line 3 and 11) were then selected for backcrossing and then mated with the wild-22 type C57BL/6J mice. Speed congenics was performed to select the heterozygous males from each 1 generation for breeding, and to ensure that >99% of the BDF1 background was replaced with the 2 C57BL/6J background. Line 11 was backcrossed a total of 6 generations before proceeding with 3 experiments.
4
Diet induced obesity studies 5 At the age of three weeks, mice (n=8) were placed on high fat chow (60% fat kCal, TD.06414) or 6 control chow (10% fat kCal, TD.0.8806)) for 6 weeks. All diets were provided from Teklad 7 Laboratories (Chicago, IL). At the end of the 6 week treatment period mice were sac'd and 8 mitochondria was extracted from SKM and BAT using the previously described procedure.
9
Fasting and cold-exposure studies 10 Male mice between the ages of 7.5-8.5 weeks old were fasted for 18hrs in individually housed 11 cages with fresh bedding. The body weight of each mouse was recorded before and after fasting 12 treatment. Any mouse under 21g was excluded from the study. Cold tolerance was then tested by 13 placing mice in a temperature-controlled room at 4°C for 3-6 hours, or until body temperature 14 dropped below 25°C. Core body temperatures was recorded prior to cold-exposure and every hour 15 during treatment with a rectal temperature probe (Physitemp, Clifton, NJ) .
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Mitochondrial isolation 17 C2C12 cells were homogenized with a 27.5 gauge needle in CP-1 buffer supplemented with 18 protease and phosphatase inhibitors. Homogenates were then centrifuged at 500g for 10 minutes 19 at 4˚C twice, making sure to discard pellets and re-aliquot supernatant in to new tubes in between 20 spins. After second spin, the supernatant was collected and spun at 10,500 g for 10 minutes at 1 4˚C to pellet mitochondria.
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Brown adipose tissue, SKM, and heart tissue samples were isolated from mice and finely minced 3 in either CP-1 buffer or 100mM KCl, 500mM Tris-HCl, 2mM EGTA, 1mM ATP, 5mM MgCl2, 4 0.5% BSA, pH 7.4 supplemented with protease and phosphatase inhibitors. Tissues were then 5 homogenized with a Teflon pestle drill press in smooth glass homogenizers. Homogenates were 6 then centrifuged at 800g for 10 minutes at 4˚C twice, making sure to discard pellets and re-aliquot 7 supernatant in to new tubes in between spins. After the second spin, homogenates were applied to 8 a 70µm cell strainer and then centrifuged at 10,500g for 10 minutes at 4˚C to pellet mitochondria. Immunoprecipitation samples (IP) were prepared using 250-500µg of protein and adjusted to 4 300µl with the previously described immunoprecipitation buffer. Samples were then incubated 5 with either 1µg of primary antibody or IgG (for controls) at 4˚C for 16 hours with rotation. Protein 6 G Sepharose beads were blocked in 5% BSA in PBS overnight as previously described. Thirty 7 microliters of Protein G Sepharose beads were then added to each immunoprecipitation sample 8 and rotated at 4˚C for 5 hours. Samples were washed 8 times with wash buffer, after then prepared 9 for SDS polyacrylamide gel electrophoresis (PAGE). Twenty-four hours after transfection C2C12s were fixed and permeabilized in 2.5% 20 paraformaldehyde and 0.1 % TritonX-100 at RT for 20 minutes. The cells were then incubated 21 with either anti-Myc or the peroxisomal marker anti-catalase (Abcam, Cambridge, MA), followed 1 by secondary anti-mouse Alexa 568 or anti-rabbit Alexa 488. All fluorescent images were 2 acquired with a Nikon Eclipse Ti-S microscope, 60x Nikon Plan Apo VC Oil objective with 3 numerical aperture 1.40. Images were captured with Photometrics Coolsnap EZ camera and 4 processed using Nikon NIS Elements BR 3.0 software.
5

Myocyte oxygen consumption 6
Respiration rates in SKM myocytes were quantified using a fiber-optic fluorescence oxygen 
Analysis of variance comparisons between genotypes were analyzed by a student's t-test or single
Identification of the interaction between ECH1 and UCP3
3 UCP3 is a 6-transmembrane (TM) domain-containing protein with 7 hydrophilic (HD) 4 connecting loop domains ( Figure 1A , HD1-7). We adapted a yeast two hybrid screen to identify 5 UCP3 binding partners and used the seven HD UCP3 domains as baits in yeast expressing a human 6 heart cDNA library, leading to the identification of ECH1 as a candidate UCP3 interacting protein.
7
This approach revealed that HD1, 3, and 4, but not HD2, 6, or 7 interacted with full length ECH1 8 ( Fig. 1B ).
9
We first tested the ECH1:UCP3 interaction in mammalian cells by co-transfecting cells 10 with a V5-tagged mouse UCP3 construct (UCP3-V5) and Myc-tagged mouse ECH1 construct 11 (ECH1-Myc). Lysates were immunoprecipitated with anti-Myc antibody and co-12 immunoprecipitated UCP3-V5 was detected by immunoblotting with anti-V5 antibody. Results
13
showed that UCP3-V5 was immunoprecipitated with anti-Myc ( mouse myoblasts that were differentiated in low serum media (2% equine serum) showed an 20 induction of UCP3 mRNA and protein expression levels ( Fig. 1E , upper blot, days 2-6).
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Interestingly, the data showed that endogenous ECH1 mRNA and protein levels did not change 22 upon differentiation ( Fig. 1D ). We then tested whether the ECH1:UCP3 complex could be 23 14 detected in differentiated C2C12 myotubes when both proteins were present at physiological 1 concentrations. Using lysates from differentiated myotubes, we found that endogenous ECH1 2 could be detected when immunoprecipitated with anti-UCP3, but not with rabbit anti-IgG in 3 C2C12 myotubes (Fig. 1F ).
4
To test whether UCP3 and ECH1 formed a direct complex, we used purified recombinant 5 UCP3 and ECH1 proteins and performed in vitro pull-down experiments. Full length UCP3 6 protein with an N-terminal GST tag (GST-UCP3) was expressed and purified from bacteria, along 7 with recombinant ECH1 protein that lacked its mitochondrial targeting sequence and was linked 8 to a C-terminal 6X His tag (ECH1∆MTS-6XHis) ( Fig. 1G ). Immunoprecipitation experiments 9 with the purified proteins demonstrated that GST-UCP3 was able to pull down ECH1∆MTS-10 6XHis in vitro (Fig. 1H , Lane 2). As expected, ECH1∆MTS-6XHis was not pulled down in either 11 beads (Lane 8) or GST (Lane 1) alone. cellular distribution in muscle (or tissues other than liver? Or any tissue?) has not been described.
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To examine whether ECH1 localization is predominantly mitochondrial or peroxisomal, 21 immunocytochemistry was performed in C2C12 myocytes that were co-transfected with ECH1-
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Myc and either Mito-GFP or empty vector control plasmid. Pearson's correlation coefficient was 23 used to quantify the subcellular localization of ECH1, and revealed that ECH1 localizes 1 predominantly to mitochondria based on the co-localization of immunofluorescent staining for 2 ECH1 with Mito-GFP ( Fig. 2C ). Endogenous staining of catalase was used as a peroxisomal 3 marker. 4 It is likely that UCP3 shares a similar protein structure to other members of the 5 mitochondrial carrier protein family such as ANT. Based on the topology predictions and crystal 6 structure of ANT (Notario et al. 2003) , it is thought that these proteins have N-and C-terminal 7 hydrophilic domains that face both sides of the inner mitochondrial membrane. Thus, the 8 hydrophilic UCP3 domains 1, 3, 5, and 7 are localized in the intermembrane space, and domains 9 2, 4, and 6 localize to the matrix. Because the bait constructs HD1, 3, & 4 captured ECH1 in the 10 yeast two-hybrid analysis ( Fig. 1 A-B ) it is possible that ECH1 could interact with UCP3 on either 11 or both sides of the inner mitochondrial membrane. In order to define the sub-mitochondrial 12 localization of ECH1 we performed a digitonin-based localization assay on mitochondria isolated 13 from C2C12 myotubes. As indicated in Fig. 2B , mitochondria were treated with proteinase K (Pro and DIG treatments to a similar degree as aconitase, indicating that ECH1 localizes to the 1 mitochondrial matrix. As mentioned above, the yeast two hybrid results identified HD 1, 3, and 4 as potential 5 interaction motifs. Next, we sought to map the UCP3-interaction motifs that are necessary for 6 complex formation with ECH1 by generating a series of V5-tagged (C terminus) UCP3 truncation 7 mutants lacking the indicated HD displayed in Figure 3A . Cells co-transfected with ECH1-Myc 8 and either full-length UCP3-V5 or the UCP3 truncation mutants were lysed and 9 immunoprecipitated with anti-Myc. Absence of hydrophilic domain 4 (ΔHD4) caused a 10 significant decrease in the amount of UCP3 co-immunoprecipitated with ECH1-Myc ( Fig. 2D,   11 lane 7). These results indicate that complex formation between ECH1 and UCP3 is mediated 12 through HD4, which is the central matrix loop of UCP3. Furthermore, additional co-13 immunoprecipitation studies with V5-tagged HD4 mutants, each lacking one third of the domain, 14 showed that ECH1 and UCP3 likely interact via the first 12 amino acids of the central matrix loop 15 of UCP3 ( Figure S1 ).
17
Fatty acid regulation of complex formation between ECH1 and UCP3 18 We then focused on defining the biochemical and physiological factors that regulate ECH1 19 and UCP3 complex formation. We generated Myc-tagged ECH1 catalytic mutants to address 20 whether the mutants could be co-immunoprecipitated with UCP3-V5 in lysates extracted from co-21 transfected cells (Fig. 4A ). According to previous structural and mechanistic studies of ECH1, the Figure 4A ). Interestingly, the ECH1 mutant D176N-Myc that still possesses catalytic activity did 5 not have the same attenuated effect on complex formation with UCP3-V5. However, introducing 6 the E196Q mutation to generate D176N/E196Q-Myc restored the loss of interaction with UCP3-7 V5, thus indicating that ECH1 catalytic activity is important in ECH1 and UCP3 complex 8 formation (Fig. 4A ).
9
Having established that modifying ECH1 catalytic activity can affect complex formation 10 between ECH1 and UCP3, we reasoned that complex formation between ECH1 and UCP3 might 11 be stimulated by the presence of FAs. To test this hypothesis, we blocked FA import into the 12 mitochondria by inhibiting the key mitochondrial FA transporter, carnitine palmitoyl transferase I 13 (CPT1) with the drug etomoxir. Co-immunoprecipitation experiments were performed in lysates 14 extracted from HEK293T cells co-transfected with UCP3-V5 and ECH1-Myc, and then treated 15 with 75µM etomoxir. Densitometry analyses of immunoblots detecting the amount of UCP3-V5 16 co-immunoprecipitated with ECH1-Myc showed a significant decrease in ECH1:UCP3 complex 17 formation in the etomoxir treated cells compared to vehicle treated (Fig. 4B) . These results 18 indicate that complex formation between ECH1 and UCP3 is stimulated by FAs, and could thus 19 be physiologically relevant in metabolic pathologies where FAs serve as a primary fuel source for 20 mitochondria. Consistent with these findings, we observed a ~1.5 and 2 fold increase in ECH1 21 and UCP3 protein expression levels, respectively, in isolated SKM mitochondria from mice fed 22 high-fat diets for 6 weeks (Fig. 4C ). Body weights were significantly higher in the mice fed high 23 fat diets, thus affirming that the changes in ECH1 and UCP3 protein expression were correlated 1 with the degree of obesity in our animals ( Supplementary Fig. 2 ).
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To characterize the functional influence of the ECH1:UCP3 complex on mitochondrial 3 metabolism in SKM we utilized the Precision Lenti-ORF plasmids (pLOC) to generate stable cell 4 lines in C2C12 myoblasts that either overexpresses ECH1 (C2C12-ECH1) or empty vector pLOC 5 (C2C12-EV). Stables colonies of both cell lines were selected and densitometry analyses 6 confirmed protein overexpression of ECH1 in the C2C12-ECH1 cell lines at physiological levels 7 ( Fig. 5A ) that were similar to the induction of ECH1 expression in SKM of mice fed high fat diets 8 ( Fig. 4C) . Given that UCP3 function is closely tied to FA metabolism, if ECH1 forms a direct 9 complex with UCP3 in the presence of FAs it is possible that complex formation could regulate 10 UCP3 activity, thus enhance uncoupled respiration. To investigate this notion we transfected 11 UCP3-V5 in to our stable cell lines C2C12-ECH1 and -EV and measured uncoupled respiration 12 using a fiber-optic fluorescence oxygen monitoring system. As shown in Figure, oligomycin-13 induced uncoupled respiration was higher in cells overexpressing ECH1 and UCP3-V5 compared 14 to cells expressing UCP3-V5 alone. We then set out to examine the consequences of the 15 ECH1:UCP3 complex formation on the ECH1-dependent metabolism of unsaturated fatty acids 16 through quantification of radiolabeled oleate oxidation in our stable cell lines transfected with 17 UCP3-V5. Consistent with previous observations, UCP3 expression alone led to a slight increase 18 in oleate metabolism (Fig. 5C ). Interestingly, ECH1 and UCP3 overexpression led to a synergistic 19 increase in oleate oxidation. 
Physiological Relevance of ECH1 and UCP3 in Metabolic Stress
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The thermogenic capabilities of UCP3 remain controversial. Even though UCP3 knockout 1 (UCP3 -/-) mice do not exhibit a clear cold-intolerant or obese phenotype, there is significant 2 evidence to support the role of UCP3 in maintaining energy balance in metabolically challenging 3 conditions where FA oxidation is high. Indeed, experiments demonstrating that fasted UCP3 -/-4 mice have impaired rates of FA oxidation along with elevated levels of FA matrix accumulation, 5 suggest that UCP3 is necessary for mitochondrial adaptation to fasting (Seifert et al. 2008) . Given 6 that FA metabolism and transport is essential in driving cold-induced thermogenesis, we tested 7 whether the absence of UCP3 would affect cold-induced thermogenesis in fasted mice. 8 Suprisingly, we found that UCP3 -/-mice (between the ages of 7-8.5 wks) fasted for 18 hours were 9 more sensitive to cold after 6 hours compared to the wild type ( Fig. 6A ).
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Like UCP3, it has been proposed that ECH1 may play a crucial role in the protection against lipid 11 overload in conditions of high metabolic stress when FAs serves as the primary source of energy. Fig.2A-C) . Analyses of ECH1 expression by western blot confirmed a complete loss of ECH1 expression in 1 SKM, BAT, and HRT (Fig. 6B ). We then subjected these mice to 18hr fasting and cold stress 2 (4°C) and monitored changes in core body temperature. Similar to the wild-type group, the ECH1-3 /-mice showed a slight decrease in body temperature following fasting treatment compared to the 4 fed groups (Fig. 6C, 0 hrs) . However, the fasted ECH1 -/-mice were unable to maintain core body 5 temperature during acute cold exposure at 4°C (Fig. 6D) . Interestingly, the body weights of the 6 wild-type and ECH1 -/-mice were not different in the fasted and fed groups, thus indicating that the 7 thermogenic phenotype seen in the ECH1 -/-mice was independent of any differences in body weight 8 following fasting (Fig. 6E ). We also found that the ECH1 -/-mice did not exhibit a difference in 9 mRNA expression levels of the canonical cold-induced thermogenic genes in brown adipose tissue 10 UCP1, Dio2, and Pgc1 (Fig. 6F) . These results suggest that the signaling downstream of adrenergic 11 stimulation of BAT in response to cold exposure is intact in the ECH1-/-mice and is not likely 12 contributing to the severe cold-intolerant phenotype. Surprisingly, when we looked at UCP3 13 protein expression in SKM following fasting and acute cold exposure treatments, we found that 14 ECH1-/-mice had higher levels of UCP3 compared to wild type. Taken together, this 15 compensatory increase in UCP3 corroborates the synergistic relationship between ECH1 and 16 UCP3 in skeletal muscle metabolism. Thus, the ECH1-/-mice are unable to maintain core body 17 temperature despite the compensatory increase in UCP3 protein expression in SKM. 20 There is considerable evidence to support that UCP3 has the ability to regulate FA 21 metabolism and transport to protect SKM mitochondria against FA overload (lipotoxicitiy) and 22 insulin resistance, but only when activated in certain physiological contexts. FAs have been 1 implicated as potent activators of UCP function (Jiménez-Jiménez et al. 2006; Skulachev 1999; 2 Hagen & Lowell 2000), however significant debate exists regarding the mechanisms by which 3 FAs activate UCP3, and by which UCP3 regulates FA metabolism. Our work demonstrating that 4 the auxiliary unsaturated FA metabolizing enzyme ECH1 interacts with UCP3 in the mitochondrial 5 matrix, at endogenous levels, supports a mechanism by which UCP3 can facilitate FA transport 6 and influence mitochondrial metabolism. Importantly, we also demonstrate that UCP3 and ECH1 7 are both important in facilitating an adaptive response to metabolic stress, and that complex 8 formation between these proteins could be key in regulating a thermogenic response to acute cold 9 exposure in a fasted state.
19
Discussion
10
The characterization of the ECH1:UCP3 complex sheds new light on how the specific 11 metabolism of polyunsaturated FAs with odd-numbered double bonds contributes to mitochondrial 12 energy balance. ECH1 is a unique enzyme in that it demonstrates dual-organelle distribution to 13 the peroxisomes and mitochondria in mammalian cells. The enzyme contains a known type I 14 peroxisomal targeting sequence (SKL) in its C-terminus (Filppula 1998), and it has also been 15 shown that the first 40 amino acids in the N terminus resembles a cleavable mitochondrial targeting 16 signal as predicted by Mitoprot II analysis (Claros & Vincens 1996) . While mitochondrial FA 17 metabolism is a major contributor to energy production and balance, peroxisomal FA oxidation is 18 not. Indeed, FA metabolism in peroxisomes is only capable of shortening the fatty acyl-CoA 19 chains, while the complete degradation of the fatty acyl-CoA chain to generate ATP occurs 20 exclusively in the mitochondria. Therefore, our finding that ECH1 localizes primarily to the 21 22 mitochondria rather than peroxisomes is consistent with previous studies that ECH1 is important 1 in maintaining pools of coenzyme A and regulating energy balance.
2
It has been proposed that ECH1 plays an important role in the disposal of unmetabolizable 3 FA metabolites (Shoukry & Schulz 1998) . ECH1 is an essential auxiliary enzyme in the reductase-4 dependent pathway that is responsible for catalyzing the isomerization of the 3,5-dienoyl-CoA 5 substrate to 2,4-dienoyl-CoA. This is regarded as a crucial step in the reductase-dependent pathway 6 because unlike other FA-intermediates that can be metabolized by redundant FA enzymes, the 3,5-7 dienoyl-CoA substrate is a "dead end metabolite" that is exclusively metabolized by ECH1. Based 8 on these realizations it was later suggested that the reductase-dependent pathway be renamed to 9 the ECH1-dependent pathway (Shoukry & Schulz 1998) given that in the absence of ECH1 10 activity, the "dead end metabolite" would accumulate, sequester coenzyme A, and halt 11 mitochondrial b-oxidation.
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Interestingly, the proposed physiological function of ECH1 is similar to previous theories 13 by Harper et al. that suggest UCP3 also protects against lipotoxicity by facilitating FA transport to 14 maintain coenzyme A availability in conditions that require high levels of FA oxidation. In support 15 of this notion, UCP3 expression is induced in response to high fat feeding and fasting, thus 16 suggesting a role for UCP3 in conditions where the rates of mitochondrial FA oxidation are high.
17
Furthermore, it has also been shown that UCP3 overexpression in SKM can lower circulating 18 levels of acylcarnitines and thus facilitate complete FA oxidation (Aguer et al. 2013) . Based on 19 these findings, it makes sense that UCP3 would interact with a FA metabolizing enzyme to mediate 20 efficient FA oxidation. Accordingly, our data demonstrating that ECH1:UCP3 complex formation 21 is regulated through FAs and likely activated in conditions that require enhanced levels of FA 22 oxidation e.g. high fat feeding, suggests these two proteins could be facilitating a compensatory 1 response to metabolic FA overload. Indeed, our data proposes a modified model by which UCP3 2 functions to maintain coenzyme A availability in part through ECH1-dependent metabolism of 3 unsaturated FAs. The finding that UCP3 and ECH1 expression synergistically increases oleic acid 4 oxidation suggests that UCP3 binding could enhance ECH1 activity and promote unsaturated FA 5 oxidation. In addition to this, we also demonstrate that ECH1 and UCP3 expression synergistically 6 enhances uncoupled respiration in C2C12 myocytes. Taken together, it is tempting to speculate 7 that complex formation between ECH1 and UCP3 functions to coordinate FA oxidation and 8 uncoupling activity in a compensatory pathway that is activated in situations that require enhanced 9 levels of FA oxidation.
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Despite the numerous debates regarding the thermogenic capabilities of UCP3 in SKM, 11 results herein demonstrate the UCP3 is important in mediating an adaptive thermogenic response 12 to cold temperatures, in a fasted state. The assumption that UCP3 is not a physiological 13 thermogenic regulator stems from the finding that UCP3 -/-mice are able to maintain core body 14 temperature in response to cold. However, the lack of a cold-phenotype may be due to a 15 compensatory process, but it does not necessarily exclude the possibility that UCP3 can contribute 16 to whole-body thermogenesis through alternative mechanisms that may be crucial in different 17 physiological contexts. Indeed, UCP3 has been shown to be a crucial molecular mediator of non- UCP3 expression in certain physiological contexts where mitochondria rely predominantly on FA 22 metabolism, along with mechanistic studies in fasted mice, suggest that UCP3 may be relevant in 1 mediating an adaptive increase in FA oxidation capacity in SKM (Seifert et al. 2008) . Given that 2 fasting and cold exposure are both stimulators of FA oxidation, it is likely that the absence of 3 UCP3 diminishes efficient FA handling in response to these metabolic stressors, thus diminishing 4 optimal cold-induced thermogenesis in UCP3 -/-in a fasted stated.
5
Lastly, we demonstrate for the first time that unsaturated FA metabolism through the 6 reductase/ECH1-dependent pathway is essential for thermogenesis in conditions of severe 7 metabolic stress. The impaired thermogenic phenotype seen in the ECH1 -/-mice in response to 8 fasting is similar to previous studies with mice lacking dienoyl-CoA reductase, an auxiliary 9 enzyme involved in the metabolism of all species of unsaturated FAs (odd-and even-numbered shows that impairment of this metabolic pathway can have a significant effect on whole-body 14 thermogenesis in fasted conditions. Taken together, this data shows that ECH1 is an essential 15 regulator of cold-induced thermogenesis in a fasted state, through a mechanism that is mediated in 16 part through UCP3-dependent activity in SKM. A.
